// App-Quantinova.ai

Sa1283 : THE PERFORMANCE OF TISSUE TRANSGLUTAMINASE ANTIBODIES FOR DIAGNOSIS OF CELIAC DISEASE IS DECREASED IN ADULTS ACCORDING TO OTHER COMORBIDITIES

Researchers

Presenter

  • Gabriel Bernard

Principal Investigators

  • Nancy Presse

  • Pierre-Olivier Hetu

  • Catherine Vincent

  • Mickael Bouin

Medical Centers

  • Department of Biochemistry, Centre de recherche du Centre Hospitalier de -Universite de Montreal, Montreal, Quebec, Canada

  • Department of Surgery, Universite de Montreal, Montreal, QC, Canada

  • Centre de Recherche du Centre Hospitalier de lUniversite de Montreal, Montreal, QC, Canada

  • Department of Biochemistry, Centre de recherche du Centre Hospitalier de -Universite de Montreal, Montreal, Quebec, Canada

  • Department of Biochemistry, Centre de recherche du Centre Hospitalier de -Universite de Montreal, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • Tissue transglutaminase

Drug/Treatment

  • N/A

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim